News

Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

Hologic, a global leader in women’s health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics for approximately $230M. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers. “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,”…

Ovia Health Joins the Digital Therapeutics Alliance as First Maternal Health Company

Ovia Health, a digital family health solution, is joining the Digital Therapeutics Alliance (DTA), a global non-profit organization with the mission of advancing digital therapeutics into healthcare. Ovia is the first maternal and family health company to join the Alliance. Since 2012, Ovia Health has helped more than 15 million people successfully navigate their parenthood journeys and is on a mission to make a…

Nike and ABOUT YOU Launch a Co-Branded Campaign Addressing the Power of the Menstrual Cycle

The menstrual cycle is still a taboo topic in public discourse. Nike and ABOUT YOU have taken this as an opportunity to address the relevant topic of the menstrual cycle in their jointly developed campaign for the launch of the new Nike SuperRep training shoe in Germany. Goal of the campaign is to motivate women to find out about their menstrual cycle…

ExEm Foam, the Only FDA-Approved Contrast Agent for Ultrasound Tubal Patency Testing Is Now Available in the U.S.

ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…

Launched on Kickstarter: NOVA H1 Is the World’s First Audio Earring

We know, we know.. This isn’t exactly healthcare related, but we thought this was a cool product and we were thrilled to see the team behind NOVA H1 Audio Earrings blow past their Kickstarter goal within hours last week. Friends, have a look at the first clip-on earphones on the planet. The earrings are fully packed with the latest technology embedded in real…

LabReady GBS, an Innovative Women’s Health Diagnostic Device to Improve the Maternal Group B Strep Testing Processes, Is Now Available in Europe

Earlier this week Vax-Immune Diagnostics annoucned that it has received CE Mark approval for its first-in-class medical device, LabReady GBS. LabReady’s Group B Strep product is the first in Vax-Immune Diagnostics’ lineup of women’s health solutions that helps avoid life-threatening complications and expensive consequences for mothers and their babies. With CE Mark approval, LabReady is now available to European physicians, patients, and hospital systems. The brainchild…

Femtech in Europe: Challenges and Opportunities

Every day we get another note about yet another startup, accelerator or European investor eager to break into women’s health innovation. Without question: Femtech in Europe is on the rise and both investors and the media are finally starting to pay attention. And while all this new traction is exciting, there are some unique opportunities, but also challenges the local ecosystem will…

Launched: LaMaria, A New Line of Skincare for Menopausal Women Created by an OB-GYN

Menopause startups are on the rise – both in numbers and in terms of the capital and attention they attract. Today another company focused on menopausal women joins their ranks: LaMaria – A skincare brand that’s pro-you instead of anti-age. The DTC company was founded by OB-GYN Dr. Manuela Maria Vazquez who wanted to create a product specifically for women undergoing hormonal…